Ikaria Inc. is one of the leading companies that deals with the research, development and commercialization of pharmaceutical gases and biologic gasomediators in the United States. It provides INOmax, which is an inhalation gas used for the treatment of hypoxic respiratory failures. The company maintains research facilities in Washington and Wisconsin and operates a manufacturing facility in Louisiana. Ikaria offers a range of drug delivery devices for various clinical and commercial applications. Its clinical research program focuses on critical care products in the areas of ischemia and reperfusion injury, cardiovascular and pulmonary medicine and surgery, transplantation, and neonatology. The company also practices in the areas of pharmacology and preclinical and clinical development. Ikaria works in partnerships with various organizations in Mexico, South America, Australia, Japan and Europe.